Furthermore, treatment with the TBK1 inhibitor BX795 resulted in increased Salmonella counts in MK2 expressing MEFs (Figure 6B) indicating a role for TBK1 in restricting Salmonella infection. Here, MAPKAPK2 is linked to Salmonella Infections.